Profile
MOTS ABT BSX-PA SYK MDT BSX
Company Name Motus GI Holdings, Inc. Abbott Laboratories Boston Scientific Corporation Stryker Corporation Medtronic plc Boston Scientific Corporation
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $0.64K $192.90B $175.45B $137.02B $131.98B $113.11B
Employees 0.02K 114.00K 45.00K 53.00K 95.00K 53.00K
CEO Ravit Ram Robert Ford Michael F. Mahoney Kevin A. Lobo Geoffrey Straub Martha Michael F. Mahoney
Ratings
MOTS ABT BSX-PA SYK MDT BSX
Quant Rating Score 1 2 3 3 1
Quant Rating Strong Sell Sell Neutral Neutral Strong Sell
Trading
MOTS ABT BSX-PA SYK MDT BSX
Last Close $0.0002 $130.03 $122.18 $360.13 $96.28 $101.76
High 52 - $140.22 $122.18 $403.53 $98.43 $108.14
Low 52 - $111.1 $122.18 $337.28 $79.61 $88.03
Price vs. 52 Week High 0 % -7.27 % 0 % -10.76 % -2.18 % -5.9 %
Price vs. 52 Week Low 0 % 17.04 % 0 % 6.77 % 20.94 % 15.6 %
Total Return
MOTS ABT BSX-PA SYK MDT BSX
1 Month Return 100 % 1.16 % 0 % -3.82 % 0.52 % 2.54 %
3 Month Return 100 % -0.18 % 0 % -5.68 % 3.74 % -1.25 %
6 Month Return 100 % -3.54 % 0 % -8.65 % 11.38 % -4.04 %
9 Month Return 100 % -0.12 % 0 % -6.61 % 11.86 % -3.41 %
YTD Return 0 % 14.96 % 0 % 0.02 % 20.53 % 13.93 %
1 Year Return -50 % 11.01 % 0 % -7.35 % 13.27 % 12.65 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
MOTS ABT BSX-PA SYK MDT BSX
Dividend Yield Percentage (TTM) - 2.17 % - 0.95 % 2.75 % -
Dividend Paid and Capex Coverage Ration (TTM) -107.63 % 1.46 % 5.44 % 2.47 % 1.29 % 5.44 %
Dividend Per Share (TTM) - 2.4 % - 3.4 % 2.83 % -
Payout Ratio (TTM) - 61.99 % - 39.56 % 75.84 % -
Growth
MOTS ABT BSX-PA SYK MDT BSX
Asset Growth -59.07 % - 11.34 % 1.89 % 12.12 %
Gross Profit Growth -22.55 % 15.39 % 10.39 % 3.58 % 16.26 %
Revenue Growth -46.11 % 5.67 % 11.16 % 3.62 % 17.61 %
Revenue 3 Year -56.95 % 1.9 % 34.71 % 10.52 % 36.16 %
Revenue 5 Year -44.77 % 29.99 % 71.94 % 20.96 % 47.52 %
Revenue 10 Year - 83.13 % 148.82 % 41.05 % 104.22 %
EBIT Growth 30.2 % 12.74 % 15.72 % 14.42 % 18.25 %
Net Income Growth 30.81 % -51.32 % 8.45 % 26.82 % 16.38 %
Net Income 3 Yeari Growth Per Share 91.16 % -5.58 % 36.22 % -3.39 % 72.31 %
Net Income 5 Yeari Growth Per Share 96.4 % 47.3 % 99.44 % 1.52 % -62.7 %
Net Income 10 Yeari Growth Per Share 86.23 % 24.34 % 122.27 % 48.51 % 1502.13 %
Operating Income Growth 33.3 % 17.92 % 11.14 % 15.77 % 20.82 %
Operating Cash Flow Growth (CFG) 35.91 % - 18.91 % 3.79 % 37.24 %
Operating 3 Year CFG 91.29 % -100 % 90.21 % 0.13 % 77.55 %
Operating 5 Year CFG 95.33 % -100 % 51.22 % 1.55 % 76.92 %
Operating 10 Year CFG 85.42 % -100 % 452.85 % 22.45 % 143.61 %
EPS Growth 81.56 % -51.24 % 8.02 % 31.05 % 16.61 %
EPS Diluted Growth 81.56 % -51.31 % 8.25 % 30.8 % 16.52 %
Book Value Per Share -75.93 % -100 % 8.31 % -1.16 % 11.25 %
Share Holder 3 Year Equity Growth Per Share -96.85 % -100 % 33.52 % -4.58 % 26.58 %
Share Holder 5 Year Equity Growth Per Share -99.1 % -100 % 68.35 % -1.29 % 48.35 %
Share Holder 10 Year Equity Growth Per Share 104.63 % -100 % 159.56 % -23.12 % 186.31 %
Dividend Per Share Growth - 6.54 % 5 % 1.11 % -100 %
Dividend 3 Year Growth Per Share - 25.03 % 20.89 % 10.78 % -100 %
Dividend 5 Year Growth Per Share - 63.45 % 46.18 % 29.33 % -
Dividend 10 Year Growth Per Share - 140.85 % 142.84 % 128.74 % -
Debt Growth -78.42 % - 5.23 % 13.95 % 17.44 %
Free Cash Flow Growth 36.14 % - 22.83 % -0.29 % 55.31 %
Updated On 31 Dec 2023 31 Dec 2025 31 Dec 2025 30 Apr 2025 31 Dec 2024
Profitability
MOTS ABT BSX-PA SYK MDT BSX
Gross Profit Margin TTM -78.37 % 55.51 % 65.05 % 63.54 % 62.27 % 69.01 %
Return on Assets TTM -178.14 % 7.75 % 6.53 % 6.78 % 5.22 % 6.77 %
Return on Equity TTM -454.34 % 13.18 % 12.42 % 15.04 % 9.83 % 12.87 %
Return on Capital Employed TTM -301.21 % 11.56 % 8.97 % 14.07 % 7.63 % 10.62 %
Net Income Per EBT TTM 100 % 77.06 % 85.26 % 71.91 % 83.61 % 85.38 %
EBT Per Ebit TTM 108.06 % 105.19 % 97.5 % 80.09 % 91.74 % 85.24 %
EBIT Per Revenue TTM -3732.6 % 18.16 % 17.33 % 22.44 % 17.87 % 19.78 %
Cash Flow To Debt Ratio TTM -453.57 % 70.47 % 38.4 % 33.95 % 24.44 % 38.4 %
Receivables Turnover TTM 4.2 4.26 6.84 6.22 5.44 7.1
Payables Turnover TTM 0.31 4.78 6.75 - 5.08 6.21
Inventory Turnover TTM 2.32 2.94 2.32 1.72 2.13 2.13
Fixed Asset Turnover TTM 26.54 % 385.33 % 451.15 % 647.99 % 485.18 % 468.06 %
Asset Turnover TTM 4.42 % 52.66 % 45.31 % 52.5 % 38.05 % 47.01 %
Operating Cash Flow Per Share TTM -13.83 5.22 3.12 13.19 5.55 3.12
Free Cash Flow Per Share TTM -13.96 3.96 2.55 11.2 4.06 2.55
Cash Per Share TTM 612.47 % 442.64 % 86.05 % 1071.9 % 649.63 % 85.99 %
Operating Cash Flow Sales Ratio TTM -3509.09 % 20.57 % 23.91 % 20.08 % 20.46 % 23.04 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.93 % 75.85 % 81.6 % 84.91 % 73.19 % 81.6 %
Cash Flow Coverage Ratios TTM -453.57 % 70.47 % 38.4 % 33.95 % 24.44 % 38.4 %
Price To Free Cash Flows Ratio TTM - 27.89 35.99 31.99 25.35 29.96
Price To Operating Cash Flows Ratio TTM - 21.23 29.35 27.17 18.54 24.45
Price Cash Flow Ratio TTM - 21.23 29.35 27.17 18.54 24.45
Income Statement (TTM)
MOTS ABT BSX-PA SYK MDT BSX
Revenue $0B $44.33B $20.07B $25.12B $33.54B $20.07B
Gross Profit $-0B $24.61B $13.85B $15.43B $21.91B $13.85B
Gross Profit Ratio -78.37% 55.51% 69.01% 61.44% 65.32% 69.01%
EBITDA $-0.01B $11.33B $3.73B $5.69B $9.22B $3.73B
Net Income $-0.01B $6.52B $2.89B $3.25B $4.66B $2.89B
EPS Diluted -15.89 3.72 1.94 8.4 3.61 1.94
Balance Sheet (MRQ)
MOTS ABT BSX-PA SYK MDT BSX
Long Term Debt $0B $13.52B $9.37B $14.86B $25.64B $9.37B
Total Liabilities $0B $33.51B $17.39B $25.42B $43.42B $17.39B
Total Equity $0B $47.9B $22B $22.42B $48.26B $22B
Total Investments $0B $1.24B $0.56B $0.09B $6.75B $0.56B
Total Debt $0B $15.28B $11.15B $14.86B $28.52B $11.15B
Total Assets $0.01B $81.41B $39.4B $47.84B $91.68B $39.4B
Cash Flow Statement (TTM)
MOTS ABT BSX-PA SYK MDT BSX
Net Income $-0.01B $13.4B $1.85B $3.25B $4.69B $1.85B
Inventory $0B $-0.06B $-0.23B $0B $-0.29B $-0.23B
Dividends Paid $0B $-3.84B $0B $-1.28B $-3.59B $0B
Operating Cash Flow $-0.01B $8.56B $3.44B $5.04B $7.04B $3.44B
Capital Expenditure $-0B $-2.21B $-0.79B $-0.76B $-1.86B $-0.79B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 110.83
ADGM Adagio Medical Holdings, Inc. 0.99
AEMD Aethlon Medical, Inc. 2.23
AFIB Acutus Medical, Inc. 0.0002
AHCO AdaptHealth Corp. 10.65
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 187.6
ALUR Allurion Technologies Inc. 1.1
AMIX Autonomix Medical, Inc. Common Stock 0.3984
ANIK Anika Therapeutics, Inc. 10.46
AORT Artivion, Inc. 39.59
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 3.88
ARAY Accuray Incorporated 0.62
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 13.82
AVNS Avanos Medical, Inc. 14.59
AVR Anteris Technologies Global Corp. Common Stock 5.49
AXDX Accelerate Diagnostics, Inc. 0.034
ETFs With Exposure to MOTS
Ticker ETF Name Weight Percentage Price
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 151.14
VXF Vanguard Extended Market Index Fund 0 217.96
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 165.43
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 165.44
VEMPX Vanguard Extended Market Index InstlPlus 0 408.25
Unlock